leonth

7 ms·

31.
by leonth 12y ago
But the argument still stands, right? Who will be responsible if the "extremely well-understood drugs" have some problems in the US? They don't care about US population because it is such a small market for them. Let's s
32.
by leonth 12y ago
The answer may be one of: * US pharma is developing a me-too / copycat drug that has very similar molecular structure * US pharma has tried and it failed before public announcement (oh there are so many of them) * US pharma negotiated
33.
by leonth 12y ago
Imagine that there were no FDA Iron Curtain and doctors prescribed afobazole because "the paper was good" (or more likely because the money was good). Then people taking this drug got hospitalized left and right (or - shudder - fo
34.
Visualize before you analyse data(leontius.net)
1 points by leonth 12y ago|0 comments
35.
by leonth 12y ago
Haha. Fancy seeing your post again :)
36.
by leonth 12y ago
I'm a pharmacist, but since my boss knows I'm good with computers, she put me to manage the IT systems used by the pharmacy department. This role is well-defined and there is at least one full-time staff in each public hospital he
37.
by leonth 12y ago
The article glosses over the fact that wards rounds are typically an exercise that requires vast amount of highly dimensional data. Hidden in the article is the requirement that the information - lab values, vitals, patient location /
38.
by leonth 12y ago
I don't think OCR will work that well in this case. Assuming the OCR is able to detect the letters, at least from my experience, they like to draw stuff, write things in uneven 2-column or 3-column format, and make use of shorthand sym
39.
by leonth 12y ago
Do you see value in having longitudinal / long-term trend of the pulse, BP, etc? Intra-day variance may be very high, but wouldn't there be value of having an average of 100 measurements over a month, as compared to the 2 measurem
40.
by leonth 12y ago
Nice to hear back from you. Seriously what are the odds of meeting another pharmacist in HN? :) Your situation seems to be very fortunate and I'm sure that heading to pharmacy is something your parents are pushing for :) Since you&#x27
41.
by leonth 12y ago
Greetings. I was exactly at the same position two years ago but decided to get my license and work as a pharmacist instead. I am not sure how invested you are against working as a pharmacist, but I would humbly suggest that you at least do
42.
by leonth 13y ago
> Many of the problems in healthcare involve two systems that need data from each other. This. From my limited experience, even with all the systems able to talk HL7, apparently what message segments the system sends, the message segment
43.
by leonth 14y ago
What you describe here has been happening in Singapore public sector for quite some time. Most patients in a hospital will fill their prescriptions in the hospital pharmacy anyway to enjoy subsidies. Some patients still prefer to have some
44.
by leonth 15y ago
Yes it is. It is not about the cost of comparing 2 products, it is about market saturation. When 2010 came, drug A would be off-patent and evidence for using A would be piling up. As a doctor that cares about his patient, one would very rea
45.
by leonth 15y ago
It does not go down. The more drugs we know, the harder it is to prove that the new drug you propose is better than current therapy. A proposed molecule that does not have significant advantage compared to the current gold standard will nev
46.
by leonth 15y ago
I am not terribly familiar with the process, but I assure you it includes: early computational simulations of the prospective molecules; testing on lab animals; testing on healthy people; testing on small (a few hundred) number of patients;
47.
by leonth 15y ago
Truth is, clinical trials are mind-bogglingly expensive and takes years for turnover. Also some newer drugs (I'm not sure about Nexavar) are rightfully expensive to manufacture due to requirements in equipment, sterile conditions, etc. If I
48.
by leonth 15y ago
I am not a clinician (yet), but the result of a study of 11 people is hardly "actual evidence". Even if it actually does all these things, you never know what bad things will happen when you take resveratol more than 30 days. "Over 400 gene